Article
Efficacy and Safety of Fentanyl Inhalant for the Treatment of Breakthrough Cancer Pain: A Multicenter, Randomized, Double- blind, Placebo-controlled Trial
2024-03-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>Breakthrough cancer pain (BTcP) has a negative impact on patients’ quality of life, general activities, and is related to worse clinical outcomes. Fentanyl inhalant is a hand-held combination drug-device delivery system providing rapid, multi-dose (25μg/dose) administration of fentanyl via inhalation of a thermally generated aerosol. This multicenter, randomized,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 089c4cd5-e85f-5bd7-9c5b-ba4d5288936d
- DOI
- 10.21203/rs.3.rs-4104172/v1
